Table I. 25 most significant differentially expressed proteins in PLGEM-StN analysis.
AGS Pro ID | ENSEMBL Pro ID | Gene symbol | UPCa | PCb | EA1 | EA2 | EA3 | EA4 | LT1 | LT2 | LT3 | LT5 | PR1 | PR2 | PR4 | PR7 | p valuec EA vs. LT | p value EA vs. PR | p value LT vs. PR |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% | |||||||||||||||||||
AGS_1431 | ENSSTOP00000004452 | ABAT | 12 | 60 | 16 | 22 | 19 | 18 | 11 | 2 | 7 | 14 | 29 | 41 | 48 | 23 | 1.13e−02 | 3.17e−03 | 7.01e−04 |
AGS_11191 | ENSSTOP00000005420 | ACLY | 21 | 26 | 5 | 11 | 1 | 0 | 0 | 0 | 2 | 0 | 10 | 47 | 23 | 12 | 4.51e−03 | 4.63e−04 | 5.79e−04 |
AGS_5977 | ENSSTOP00000007189 | ADFP | 8 | 27 | 5 | 8 | 8 | 6 | 4 | 2 | 5 | 2 | 0 | 0 | 0 | 0 | 4.86e−02 | 7.28e−05 | 4.16e−03 |
AGS_590 | ENSSTOP00000003215 | AKR1C3 | 17 | 71 | 33 | 95 | 28 | 59 | 63 | 39 | 79 | 77 | 77 | 201 | 132 | 61 | 5.89e−02 | 2.38e−04 | 3.43e−03 |
AGS_5442 | ENSSTOP00000000753 | AKR1D1 | 5 | 37 | 3 | 2 | 0 | 2 | 7 | 3 | 4 | 3 | 11 | 6 | 9 | 2 | 5.88e−03 | 5.26e−04 | 7.07e−02 |
AGS_15305 | None | ALB | 26 | 79 | 111 | 109 | 143 | 142 | 238 | 179 | 314 | 258 | 81 | 124 | 86 | 77 | 2.98e−04 | 1.85e−01 | 3.21e−04 |
AGS_13709 | ENSSTOP00000006409 | AOX1 | 27 | 31 | 5 | 24 | 1 | 8 | 1 | 0 | 3 | 17 | 37 | 49 | 32 | 36 | 5.82e−02 | 7.94e−04 | 1.21e−03 |
AGS_15506 | None | ARHGDIB | 5 | 45 | 2 | 3 | 5 | 4 | 0 | 0 | 1 | 0 | 2 | 5 | 0 | 5 | 4.57e−04 | 9.50e−01 | 3.19e−03 |
AGS_1099 | ENSSTOP00000007259 | BANF1 | 3 | 40 | 6 | 5 | 5 | 4 | 1 | 2 | 0 | 2 | 0 | 0 | 1 | 3 | 1.42e−03 | 8.21e−04 | 4.56e−01 |
AGS_14254 | ENSSTOP00000005260 | BHMT | 16 | 41 | 42 | 116 | 39 | 36 | 28 | 29 | 110 | 79 | 89 | 183 | 68 | 88 | 3.21e−01 | 9.20e−04 | 3.69e−03 |
AGS_15328 | None | CYP3A5 | 10 | 50 | 20 | 9 | 7 | 11 | 2 | 5 | 8 | 9 | 24 | 17 | 41 | 15 | 1.79e−02 | 2.12e−03 | 7.78e−04 |
AGS_2065 | ENSSTOP00000004232 | FABP1 | 11 | 84 | 252 | 103 | 206 | 162 | 185 | 114 | 205 | 351 | 33 | 100 | 39 | 103 | 3.11e−02 | 1.09e−04 | 4.96e−05 |
AGS_931 | ENSSTOP00000009235 | FASN | 48 | 25 | 87 | 104 | 29 | 17 | 9 | 10 | 74 | 35 | 92 | 191 | 163 | 91 | 2.82e−02 | 1.65e−03 | 8.90e−04 |
AGS_8158 | ENSSTOP00000004030 | GNG12 | 3 | 57 | 2 | 1 | 0 | 0 | 1 | 2 | 1 | 4 | 4 | 3 | 2 | 3 | 5.72e−03 | 5.03e−04 | 6.88e−02 |
AGS_2985 | ENSSTOP00000013949 | H3F3B | 4 | 56 | 4 | 7 | 16 | 14 | 4 | 7 | 0 | 3 | 3 | 1 | 6 | 0 | 3.38e−03 | 8.07e−04 | 1.78e−01 |
AGS_7005 | ENSSTOP00000003811 | HAO2 | 5 | 16 | 5 | 6 | 4 | 2 | 0 | 0 | 0 | 1 | 0 | 0 | 5 | 0 | 4.47e−04 | 1.22e−02 | 2.67e−02 |
AGS_16132 | None | HBB | 12 | 73 | 112 | 143 | 244 | 229 | 444 | 359 | 172 | 180 | 205 | 133 | 182 | 229 | 1.75e−04 | 4.40e−02 | 2.65e−03 |
AGS_18963 | None | HBE1 | 2 | 16 | 2 | 13 | 25 | 17 | 43 | 46 | 16 | 4 | 19 | 11 | 20 | 19 | 7.54e−04 | 3.05e−02 | 1.94e−02 |
AGS_17287 | None | HSD3B2 | 3 | 17 | 1 | 1 | 2 | 1 | 4 | 4 | 2 | 3 | 10 | 3 | 5 | 4 | 4.47e−03 | 3.97e−04 | 5.92e−02 |
AGS_17578 | None | MTCH2 | 7 | 48 | 8 | 9 | 6 | 8 | 2 | 0 | 2 | 2 | 5 | 4 | 5 | 5 | 7.61e−04 | 1.27e−01 | 9.86e−03 |
AGS_7129 | ENSSTOP00000002574 | NUTF2 | 4 | 63 | 4 | 4 | 4 | 2 | 0 | 0 | 1 | 1 | 2 | 2 | 2 | 0 | 5.33e−04 | 2.95e−02 | 1.94e−02 |
AGS_7834 | ENSSTOP00000005555 | PNPO | 4 | 21 | 4 | 1 | 2 | 9 | 2 | 3 | 2 | 5 | 1 | 0 | 0 | 0 | 2.41e−01 | 4.76e−04 | 7.32e−03 |
AGS_1897 | ENSSTOP00000009373 | PTMA | 5 | 37 | 12 | 19 | 11 | 7 | 0 | 3 | 5 | 3 | 5 | 2 | 4 | 9 | 3.14e−04 | 7.76e−03 | 2.72e−02 |
AGS_15424 | None | RPL14 | 5 | 27 | 5 | 9 | 11 | 17 | 3 | 2 | 2 | 1 | 2 | 3 | 7 | 2 | 8.44e−04 | 5.04e−03 | 1.24e−01 |
a Unique peptide counts.
b Peptide coverage.
c p value, FDR-adjusted p value.